August 06, 2008

Teen Stabs Parents, Anti-Depressants May Be Involved

A 14-year-old boy in the fancy Nashville suburb of Belle Mead--yep, it's where Al Gore lives--reportedly stabbed his parents in their sleep and was being treated with anti-depressants prior to the attack. The parents are OK.

Man, what is it with anti-depressants always hovering in the background of these weird, tragic events?

We'll see if there's further details on this later. Anyone want to place bets on what anti-depressant this kid was on?

Posted by Philip Dawdy at August 6, 2008 12:03 AM
StumbleUpon Toolbar del.icio.us Digg it reddit
Comments

Well in my book Paxil is the one most often associated with stabbing incidents but surely no doctors are still prescribing Paxil to young teens. Isn't it seriously out of favor now with all the publicity about withdrawal etc. etc.? It could actually be Prozac. Prozac is still touted for kids and Prozac has the longest association of them all with bizarre acts of violence.

Posted by: Sara at August 5, 2008 10:56 PM

i bet it was one of those damnable SSRIs! they, and Big Pharma, are behind this. hey, i have an even better bet: what medications do you think vince li--you know, the "paranoid schizophrenic" (scare! quotes!) who dismembered and cannibalized a fellow greyhound bus rider--was taking? i'm sure he was on, like, all of them.

oh. wait. no. he wasn't on anything. hmmm, funny that.

Posted by: aaron G at August 5, 2008 11:06 PM

Who cares Philip!
Just another story.
Nobody have even died!
You worry too much!
14 years old is already a good age to take irresponsibility for your own acts.
How can you be sure that antidepressant is involved?
I will not bet because I'm sure they won't publish the name.
Wrong. As in this case family is known they will say which one.
I truly believe that we can talk about an endemic problem.
On ssristories there has been more than 1 story a day...
And they keep on trying to sell it off-label.
If "in-label" it already is a poison... bláh blah blah....

Posted by: Ana at August 5, 2008 11:33 PM

I don't want to take bets on what med this kid was on. I have a better chance (50/50) on who the next President will be,.

I am just waiting for the press to announce that the guy on the Greyhound bus in Canada last week is Bipolar.

I bet anyone on this one, that Bipolar in some form or shape will show up in his Axis 1.


Posted by: susan at August 6, 2008 12:53 AM

i understand the advocacy you're trying to do here, but you must know that using words like 'always' in posts like this is going to get you called out.

FOR SOME, antidepressants and other drugs are over- or unnecessarily prescribed. SOME of the psychiatric drugs have harmful side effects and should never have been on the market (Zyprexa jumps to mind). not enough effort is undertaken to understand the true effects of these medications on the brain, particularly among different age groups.

You are right to point out that mental illness has many complex causes and solutions, and to criticize the use of medications as the first and only recourse in our society. But "all" and "always" are dangerous--and more often than not, inaccurate--words.

Why not at least acknowledge that for some (even if only a minority) medication has been an effective, even crucial tool for treatment? Why does it have to be a black and white issue?

Posted by: beth at August 6, 2008 10:42 AM

The father is 80 yrs old?

Posted by: Lisa at August 6, 2008 01:37 PM

"Members of the jury,
The journalist made a serious observation on his Blog, FuriousSeasons, I must remind you that a name like that already shows clearly that the journalist has biased and angry ideas towards the subject he approaches on this internet WWW... Blog, and he used the word "ALWAYS".
I must remind you that this is a display of a very disturbed mind as the Doctor Psychiatrist has already spoken while he was speaking his speech, I mean, while he was doing this testimony.
By using "ALWAYS" he, members of the jury, shows that he only see things in his own way and leaves no room for any kind of argument.
No habeas corpus and mens rea can explain such a lack of complexity of thinking and displays how simple minded the journalist is.
Members of the jury, I have just one last remark:
Have you like my shoes?

Posted by: Ana Elle Woods at August 6, 2008 02:10 PM

The father is 80; the mother is 54 and the kid is 14. I'd say there might be some good reasons why he's disturbed with this family profile. Still think the a/ds fueled the violent behavior; they do that a lot.

Posted by: Sara at August 6, 2008 04:08 PM

Misunderstandings and Popularity: SSRI/SNRI Anti-Depressants


Presently, for the treatment of depression and other what some claim are other types of mental disorders, as some claim certain mental disorders are somewhat questionable, selective serotonin reuptake inhibitors (SSRIs) are the drugs of choice by most prescribers today. Such meds, meds that affect the mind are called psychotropic medications. SSRIs also include a few meds in this class with the addition of a norepinephrine uptake inhibitor added to the SSRI, and these are referred to SNRI medications, which combined with SSRIs, are the number 1 top therapeutic class of prescriptions presently. While there are several available SSRIs presently, two SNRIs available are Cymbalta and Effexor. Some consider these classes of meds a next generation mood enhancer after the benzodiazepine hype decades ago, as there are similarities regarding their intake by others, yet the mechanisms of action are clearly different, but not their continued use by others. Furthermore, regarding SNRIs, adding the additional agent of norepinepherine is presumed to increase the effectiveness of SSRIs by some.
Some Definitions:
Serotonin is a neurotransmitter thought to be associated with mood. The hypothesis was first suggested in the mid 1960s that this neurotransmitter may play a role in moods and emotions in humans. Yet to this day, the serotonin correlation with such behavioral and mental conditions is only theoretical. In fact, the psychiatrist’s bible, which is known as the DSM, states that the definite etiology of depression remains a mystery and remains unknown with complete certainty. So a chemical imbalance in the brain is not proven to be the cause of mood disorders, it is only suspected as a result of limited scientific evidence. In fact, diagnosing mental diseases such as depression is based on subjective assessment only, as interpreted by the prescriber, so one could question the accuracy of such diagnoses.
Norepinepherine is a stress hormone, which many believe help those who have such mood disorders as depression. Basically, with the theory that by adding this hormone, the SSRI will be more efficacious for a patient prescribed such a med, as suggested earlier.
And depression is only one of those mood disorders that may exist in certain patients, yet possibly the most devastating one. An accurate diagnosis of these mood conditions lack complete accuracy, as they can only be defined conceptually, so the diagnosis or impression concluded by the patient’s doctor is dependent on subjective criteria, such as questionnaires and patient observation. A social patient history is uncertain and tricky as well, some have said. There is no objective diagnostic testing for depression. Yet the diagnosis of depression in patients has increased quite a bit over the past few decades. Also, few would argue that depression does not exist in other people to the degree that the affected patient believes their mental condition is presently. Yet, one may contemplate, actually how many people are really depressed? What is believed is that if one is disabled or impaired from a mental paradigm, treatment is necessary and appropriate with medication.
In Time magazine’s June 16th 2008 cover story, it was reported that the military personnel in the Iraq war are pounding down SSRIs often. Every time there is a new war, there is a new drug, it seems.
Several decades ago, less than 1 percent of the U.S. population were diagnosed with depression, some have said. Today, it is believed that about 10 percent of the total population in the United States have or have experienced depression at some time in their lives that may vary in severity and longevity. Why this great increase in the growth of this condition remains unknown and is subject to speculation.
What is known is that the psychiatry specialty is the one specialty most paid to by certain pharmaceutical companies for ultimately and eventual support of their psychotropic meds that they currently promote to these doctors, as this aspect of the pharmaceutical industry clearly desires market growth of these products.
Regardless, SSRIs and SRNIs are the preferred treatment methods if depression or other mood disorders are suspected by a health care provider. Yet these meds discussed clearly are not the only treatments, medicinally or otherwise, for depression and other related and suspected disease states.
Over 30 million scripts of these types of meds are written annually, and the franchise is around 20 billion dollars a year now, along with some of the meds costing over 3 dollars per tablet. There are about ten different SSRI/SRNI meds available, many of which are now generic, yet essentially, they appear to be similar in regards to their efficacy and adverse events. The newest one, a SNRI called Pristiq, was approved in 2008, and is believed to be launched as a treatment for menopause. The first one of these SSRI meds was Prozac, which was available in 1988, and the drug was greatly praised for its ability to transform the lives of those who consumed this medication in the years that followed. Some termed Prozac, ‘the happy pill’. In addition, as the years went by and more drugs in this class became available, Prozac was the one of preference for many doctors for children. A favorable book was published specifically regarding this medication soon after it became so popular with others.
Furthermore, these meds have received upon request of their manufacturers additional indications besides depression for some really questionable conditions, such as social phobia and premenstrual syndrome. With the latter, I find it hard to believe that a natural female experience can be considered a treatable disease. Social phobia is a personality trait, in my opinion, which has been called shyness or perhaps a term coined by Dr. Carl Jung, which is introversion, so this probably should not be labeled a treatable disease as well. There are other indications for certain behavioral manifestations as well with the different SSRIs or SRNIs. So the market continues to grow with these meds. Yet, it is believed that these meds are effective in only about half of those who take them, so they are not going to be beneficial for those suspected of having certain medical illnesses treated by such meds. The makers of such meds seemed to have created such conditions besides depression for additional utilization of these types of medications, which is a process known as disease mongering. Drug companies that make these medications are active and have been active in forming mutual relationships with related disease- specific support groups, such as providing financial support for screenings for the indicated conditions of their meds- which includes the screening of children and adolescents in particular, I understand. As a layperson, I consider such activities dangerous and inappropriate for several reasons.
Danger and concerns by others with these psychotropics primarily involves the adverse effects associated with these types of meds, which include suicidal thoughts and actions, violence, including acts of homicide, and aggression, among others, and the makers of such drugs are suspected to have known about these effects and did not share them with the public in a timely and critical manner. While most SSRIs and SNRIs are approved for use in adults only, prescribing these meds to children and adolescents has drawn the most attention and debate with others, such as those in the medical profession as well as citizen watchdog groups. The reasons for this attention are due to the potential off-label use of these meds in this population, yet what may be most shocking is the fact that some of the makers of these meds did not release clinical study information about the risks of suicide as well as the other adverse events related to such populations, including the decreased efficacy of SSRIs in general, which is believed to be less than 10 percent more effective than a placebo. Paxil caught the attention of the government regarding this issue of data suppression some time ago, this hiding such important information- Elliot Spitzer specifically was the catalyst for this awareness, as I recall. Furthermore, that drug is in the spotlight once again years later. Some believe the drug maker knew about possible risk to the youth as early as 1991.
And there are very serious questions about the use of SSRIs in children and adolescents regarding the possible damaging effects of these meds on them. For example, do the SSRIs correct or create brain states considered not within normal limits, which in effect could cause harm rather than benefit? Are adolescents really depressed, or just experiencing what was once considered normal teenage angst? Do SSRIs have an effect on the brain development and their identity of such young people? Do adolescents in particular become dangerous or bizarre due to SSRIs interfering with the myelination occurring within their still developing brains? No one seems to know the correct answer to such questions, yet the danger associated with the use of SSRIs does in fact exist. It is observed in some who take such meds, but not all who take these meds. Yet health care providers possibly should be much more aware of these possibilities, possibly, along with the black box warning now on SSRI prescribing information for the youth that has existed since 1994.
Finally, if SSRIs or SNRIs are discontinued by a patient without medical supervision, withdrawals are believed to be quite brutal, and may be a catalyst for suicide in itself, as not only are these meds habit forming, but discontinuing these meds abruptly, I understand, leaves the brain in a state of neurochemical instability, as the neurons are recalibrating upon discontinuation of the SSRI or SNRI that altered the brain of the consumer of this type of med. This occurs to some degree with any psychotropic med, yet the withdrawals can reach a state of danger for the victim in some classes of meds such as SSRIs and SNRIs, it is believed.
SSRIs and SRNIs have been claimed by doctors and patients to be extremely beneficial for the patient’s well -being regarding the patient’s mental issues where these types of meds are used, yet the risk factors associated with this class of medications may outweigh any perceived benefit for the patient taking such a drug. Before these medications mentioned were developed, doctors praised trycyclics, another class of anti-depressants, in a similar manner some time ago. Considering the lack of efficacy that has been demonstrated objectively with the newer psychotropics, along with the deadly adverse events with these SSRI and SSNI meds only recently brought to the attention of others, other treatment options should probably be considered, but that is up to the discretion of the prescriber.
It is my hope that such a prescriber rules out possible other etiologies for their patients’ mental conditions before they conclude that such a patient is suffering from true mental illness requiring the medications mentioned earlier, such as asking their patients about life stressors and other medications these patients have taken in the past, for example. Because at times, a doctor can in fact do harm without intent.
“I use to care, but now I take a pill for that.” --- Author unknown
Dan Abshear
Author’s note: What has been written is based upon information and belief

Posted by: Dan at August 11, 2008 07:57 AM

which snri is least likely to have weight gain as a side effect?

Posted by: deb at April 13, 2009 04:55 PM
Post a comment









Remember personal info?






pic1.jpg

Patient Blogs. Sites.
Doctor Blogs. Sites.
Activists. News.
Social Networking. Forums.
Science. Big Pharma. Ethics.
Current Affairs
Seattle Stuff
Smoking. Stuff.

Info
About Furious Seasons
Email
Other Articles
ZYPREXA Documents
Alt ZYPREXA Documents Source
Blakemore-Brown Transcript

 Subscribe in a reader

Search


Recent Entries
$99 Left
$114 To Go
Winter Fundraiser, $134 To Go, Final Day
Ruth Lilly, Eli Lilly Heiress, Prozac Beneficiary Dies At 94
Winter Fundraiser, Final Day, Less Than $200 To Go
UCLA Psychiatrist Criticizes DSM-5
Winter Fundraiser, Barely $200 To Go
Most Popular Posts Of 2009
Winter Fundraiser, Less Than $300 Left, Let's Wrap It Up
Senate Health Care Bill Contains $1.25 Billion Gift To Sen. Stabenow
Travel Day, Comment Approval May Be Intermittent
Winter Fundraiser, Close But Stalled
Senate Health Care Reform Bill Contains Controversial MOTHERS Act, Abortion Study
Adult ADHD And Sleep Problems
Vic Chesnutt Dead At 45, Possible Suicide
Recent Comments

deb on Teen Stabs Parents, Anti-Depressants May Be Involved

Dan on Teen Stabs Parents, Anti-Depressants May Be Involved

Sara on Teen Stabs Parents, Anti-Depressants May Be Involved

Ana Elle Woods on Teen Stabs Parents, Anti-Depressants May Be Involved

Lisa on Teen Stabs Parents, Anti-Depressants May Be Involved

beth on Teen Stabs Parents, Anti-Depressants May Be Involved

susan on Teen Stabs Parents, Anti-Depressants May Be Involved

Ana on Teen Stabs Parents, Anti-Depressants May Be Involved

aaron G on Teen Stabs Parents, Anti-Depressants May Be Involved

Sara on Teen Stabs Parents, Anti-Depressants May Be Involved

Archives
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
Resources
Mental Health America
National Alliance on Mental Illness
Depression and Bipolar Support Alliance
National Institute of Mental Health
McMan Web
Powered by
Movable Type 3.2